Section one: Contracting authority/entity
one.1) Name and addresses
NHS England
7&8 Wellington Place
Leeds
LS1 4AP
Contact
Jessica Gaucher-Thompson
jessica.gaucher-thompson@nhs.net
Country
United Kingdom
Region code
UKE - Yorkshire and the Humber
Internet address(es)
Main address
Buyer's address
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Hyperbaric Oxygen Therapy (HBOT) Services for all ages (Lot 1: North West, Lot 2: North East and Yorkshire, Lot 3: East of England, Lot 4: Midlands, Lot 5: London and South East, Lot 6: South West)
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages (Lot 1: North West, Lot 2: North East and Yorkshire, Lot 3: East of England, Lot 4: Midlands, Lot 5: London and South East, Lot 6: South West).
The service is commissioned in England for two specific indications in line with NHS England Clinical commissioning policy: Hyperbaric oxygen therapy for decompression illness/gas embolism (all ages). https://www.england.nhs.uk/publication/hbot-decompression-illness-gas-embolism-all-ages/
The aim of the service is to deliver Hyperbaric Oxygen Therapy (HBOT) where clinically appropriate for those suffering from Decompression Illness (DCI) or Gas Embolism.
The key objective of the Competitive Process was to commission six (6) geographically dispersed centres for the provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages.
As a result of this procurement exercise the commissioner intends to award contracts for the following Lots:
Lot 3: East of England
Lot 5: London and South East
Lot 6: South West
The service is due to commence on 1st October 2025, for a period of 5 years with the Commissioners having the option to extend for up to an additional 1 + 1 year(s) (maximum contract duration 7 years).
Section six. Complementary information
six.6) Original notice reference
Notice number: 2025/S 000-021325
Section seven. Changes
seven.1) Information to be changed or added
seven.1.2) Text to be corrected in the original notice
Section number
II.1.4.1
Instead of
Text
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages (Lot 1: North West, Lot 2: North East and Yorkshire, Lot 3: East of England, Lot 4: Midlands, Lot 5: London and South East, Lot 6: South West).The service is commissioned in England for two specific indications in line with NHS England Clinical commissioning policy: Hyperbaric oxygen therapy for decompression illness/gas embolism (all ages). https://www.england.nhs.uk/publication/hbot-decompression-illness-gas-embolism-all-ages/The aim of the service is to deliver Hyperbaric Oxygen Therapy (HBOT) where clinically appropriate for those suffering from Decompression Illness (DCI) or Gas Embolism.The key objective of the Competitive Process was to commission six (6) geographically dispersed centres for the provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages.As a result of this procurement exercise the commissioner intends to award contracts for the following Lots:Lot 3: East of EnglandLot 5: London and South EastLot 6: South WestThe service is due to commence on 1st October 2025, for a period of 5 years with the Commissioners having the option to extend for up to an additional 1 + 1 year(s) (maximum contract duration 7 years).
Read
Text
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages (Lot 1: North West, Lot 2: North East and Yorkshire, Lot 3: East of England, Lot 4: Midlands, Lot 5: London and South East, Lot 6: South West).The service is commissioned in England for two specific indications in line with NHS England Clinical commissioning policy: Hyperbaric oxygen therapy for decompression illness/gas embolism (all ages). https://www.england.nhs.uk/publication/hbot-decompression-illness-gas-embolism-all-ages/The aim of the service is to deliver Hyperbaric Oxygen Therapy (HBOT) where clinically appropriate for those suffering from Decompression Illness (DCI) or Gas Embolism.The key objective of the Competitive Process was to commission six (6) geographically dispersed centres for the provision of Hyperbaric Oxygen Therapy (HBOT) Services for all ages.As a result of this procurement exercise the commissioner has awarded contracts for the following Lots:Lot 3: East of England - The approximate lifetime value of the contract is estimated to be £7,846,195.00.Lot 5: London and South East - The approximate lifetime value of the contract is estimated to be £7,997,444.The service commenced on 1st October 2025 and will run for a period of 5 years with the Commissioners having the option to extend for up to an additional 1 + 1 year(s) (maximum contract duration 7 years).The following lots have not been awarded under this process: Lot 1: North WestLot 2: North East & Yorkshire Lot 4: MidlandsLot 6: South West
seven.2) Other additional information
This is a Provider Selection Regime (PSR) confirmation of contract award notice. These contracts have been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. This contract has now been formally awarded using the competitive process.The decision makers for this process were the NHS England’s National Commissioning Group.There were no conflicts of interests declared in reaching the decision to award.